Officials from the Food and Drug Administration (FDA) and the Center for Disease Control and Prevention (CDC) said yesterday in a meeting with White House Covid-19 coordinator Jeff Zients that vaccine companies other than Pfizer-BioNTech such as Moderna and Johnson and Johnson “not enough data”. warned that third-dose vaccine approvals may be delayed for
An official said the third dose of Pfizer-BioNTech’s vaccine is expected to arrive by September 20, while approval of Moderna, which cannot produce satisfactory data, could be delayed by the FDA until October. .
“We are awaiting a full review and approval from the FDA and a recommendation from ACIP,” White House spokesman Chris Meagher said, referring to the CDC’s Advisory Committee on Immunization Practices (ACIP) before administering the third vaccine doses. noted.
US President Joe Biden announced on August 18 that the third dose of the booster vaccines will begin on September 20 against the more contagious Delta variant of the virus, which is spreading rapidly around the country and slowing economic recovery, and future variants.
The country’s leading infectious disease specialist, Dr. Anthony Fauci also told reporters yesterday that he believes all Americans would need to receive a third dose of mRNA vaccine to be considered fully vaccinated against Covid-19. .